
Novartis AG
LEI 5493007HIVTX6SY6XD66, SWIFT NOVRCHBSXXX
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Profile
|
Novartis manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases, oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, arthritis, vaccines and diagnostics, vision, and animal health products.
|
General information
-
Organization nameNovartis AG
-
Organization statusOperating organization
-
AddressLichtstrasse 35 Basel, Switzerland, 4056
-
Site
-
IR Site
News
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
Stocks
General information
-
Organization nameNovartis AG
-
Organization statusOperating organization
-
AddressLichtstrasse 35 Basel, Switzerland, 4056
-
Site
-
IR Site
Codes
-
LEI5493007HIVTX6SY6XD66
-
SWIFTNOVRCHBSXXX
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
ICB4,500 Health Care
-
NACE*** ***
-
NAICS*** ***
-
CIK0001114448
-
UIDCHE103867266









